Market Cap 1.20B
Revenue (ttm) 579.12M
Net Income (ttm) 175.50M
EPS (ttm) N/A
PE Ratio 5.60
Forward PE N/A
Profit Margin 30.30%
Debt to Equity Ratio 0.00
Volume 191,200
Avg Vol 432,070
Day's Range N/A - N/A
Shares Out 224.34M
Stochastic %K 29%
Beta 2.51
Analysts Hold
Price Target $4.30

Company Profile

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company's portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy. It also delivers optimized mRNAs to stimulate the production of therapeutic proteins utilizing its technology and instructs human cells to produce or secrete specific proteins in the nucleus, cytopl...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 7071 9883 0
Address:
Friedrich-Miescher-Strasse 15, Tübingen, Germany
JaredSotken
JaredSotken Oct. 24 at 8:05 PM
$CVAC Why are you even tagging me on this ticker that I am not in? Trying to justify your stupidity on $BNTX ? 😅 @taxplanr
0 · Reply
Andrewfritzen01
Andrewfritzen01 Oct. 24 at 6:57 PM
$BNTX $CVAC $PFE so… using all debt to purchase. Not a great sign of the times.
1 · Reply
Jnbond7
Jnbond7 Oct. 24 at 5:57 PM
$CVAC OMG! $CVAC finally pulled it off. $CVAC clearly stepped on its own d%ck concerning the covid-19 vaccine, but like the little engine that could, it managed to pull off a miracle.
0 · Reply
topstockalerts
topstockalerts Oct. 14 at 2:18 PM
Germany’s antitrust authority Bundeskartellamt has approved BioNTech’s acquisition of rival biotech firm CureVac, stating the deal does not threaten competition. BioNTech announced in June its plan to acquire CureVac through an all-share offer valued at about $1.25 billion (€1.08 billion) to strengthen its cancer immunotherapy portfolio. During the pandemic, both companies researched COVID-19 vaccines, but only BioNTech successfully developed and commercialized one in partnership with Pfizer. The regulator noted that BioNTech already markets the Comirnaty vaccine with Pfizer, while CureVac has no commercial products, and found no significant overlap in research activities. BioNTech is advancing several cancer immunotherapy projects, whereas CureVac’s candidates remain in early-stage trials. $BNTX $PFE $CVAC
2 · Reply
DocPharm
DocPharm Oct. 4 at 4:08 PM
$BNTX bought the other 💎 $CVAC for mRNA patents (waiting for conversion) Will they or $PFE buy the gem $ABUS / ROIV/ Genevant for the LNP patents ? Very plausible
2 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 3 at 5:50 PM
$CVAC Really good write-up that perfectly summarizes CVAC's present situation. So if you want to bring your CVAC knowledge up to date or just discover CVAC, this is required reading. https://beyondspx.com/quote/CVAC/analysis/curevac-s-mrna-evolution-from-pioneer-to-integrated-powerhouse-nasdaq-cvac
0 · Reply
DocPharm
DocPharm Aug. 18 at 7:29 PM
$CVAC still have a few thousand left - when is the conversion? And how many for how many TYIA
0 · Reply
DaxCo
DaxCo Aug. 8 at 6:39 AM
1 · Reply
taxplanr
taxplanr Aug. 6 at 2:25 AM
HHS Sec Kennedy BARDA canceling 22 malignantRNA programs $BNTX $MRNA $PFE $CVAC https://truthsocial.com/@seckennedy/114978386245597771
0 · Reply
Jbjb90
Jbjb90 Jul. 24 at 2:12 PM
$SANA $PBM $LXRX added to all three today, sold out of $CVAC
0 · Reply
Latest News on CVAC
CureVac: The Hidden Value Of The mRNA Wallet

Oct 1, 2025, 5:26 AM EDT - 24 days ago

CureVac: The Hidden Value Of The mRNA Wallet


CureVac Announces Voting Results of General Meeting

Jun 24, 2025, 4:35 PM EDT - 4 months ago

CureVac Announces Voting Results of General Meeting


Top Stock Movers Now: Oracle, Boeing, CureVac, and More

Jun 12, 2025, 12:05 PM EDT - 4 months ago

Top Stock Movers Now: Oracle, Boeing, CureVac, and More

BA ORCL


BioNTech to acquire CureVac in $1.25 billion all-stock deal

Jun 12, 2025, 7:03 AM EDT - 4 months ago

BioNTech to acquire CureVac in $1.25 billion all-stock deal

BNTX


CureVac N.V. (CVAC) Q4 2024 Earnings Call Transcript

Apr 10, 2025, 12:59 PM EDT - 7 months ago

CureVac N.V. (CVAC) Q4 2024 Earnings Call Transcript


European Patent Office declares CureVac mRNA patent valid

Mar 27, 2025, 6:22 PM EDT - 7 months ago

European Patent Office declares CureVac mRNA patent valid


CureVac: Latest GBM Data Bodes Well For Next Program Check Point

Jan 8, 2025, 4:55 PM EST - 10 months ago

CureVac: Latest GBM Data Bodes Well For Next Program Check Point


CureVac N.V. (CVAC) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 3:08 PM EST - 1 year ago

CureVac N.V. (CVAC) Q3 2024 Earnings Call Transcript


GSK Will Pay Up to $1.5 Billion for CureVac's mRNA Vaccines

Jul 3, 2024, 10:18 AM EDT - 1 year ago

GSK Will Pay Up to $1.5 Billion for CureVac's mRNA Vaccines

GSK


CureVac N.V. (CVAC) Q4 2023 Earnings Call Transcript

Apr 24, 2024, 3:12 PM EDT - 1 year ago

CureVac N.V. (CVAC) Q4 2023 Earnings Call Transcript


CureVac stock gains as COVID vaccine candidates show promise

Jan 5, 2024, 7:59 AM EST - 1 year ago

CureVac stock gains as COVID vaccine candidates show promise


JaredSotken
JaredSotken Oct. 24 at 8:05 PM
$CVAC Why are you even tagging me on this ticker that I am not in? Trying to justify your stupidity on $BNTX ? 😅 @taxplanr
0 · Reply
Andrewfritzen01
Andrewfritzen01 Oct. 24 at 6:57 PM
$BNTX $CVAC $PFE so… using all debt to purchase. Not a great sign of the times.
1 · Reply
Jnbond7
Jnbond7 Oct. 24 at 5:57 PM
$CVAC OMG! $CVAC finally pulled it off. $CVAC clearly stepped on its own d%ck concerning the covid-19 vaccine, but like the little engine that could, it managed to pull off a miracle.
0 · Reply
topstockalerts
topstockalerts Oct. 14 at 2:18 PM
Germany’s antitrust authority Bundeskartellamt has approved BioNTech’s acquisition of rival biotech firm CureVac, stating the deal does not threaten competition. BioNTech announced in June its plan to acquire CureVac through an all-share offer valued at about $1.25 billion (€1.08 billion) to strengthen its cancer immunotherapy portfolio. During the pandemic, both companies researched COVID-19 vaccines, but only BioNTech successfully developed and commercialized one in partnership with Pfizer. The regulator noted that BioNTech already markets the Comirnaty vaccine with Pfizer, while CureVac has no commercial products, and found no significant overlap in research activities. BioNTech is advancing several cancer immunotherapy projects, whereas CureVac’s candidates remain in early-stage trials. $BNTX $PFE $CVAC
2 · Reply
DocPharm
DocPharm Oct. 4 at 4:08 PM
$BNTX bought the other 💎 $CVAC for mRNA patents (waiting for conversion) Will they or $PFE buy the gem $ABUS / ROIV/ Genevant for the LNP patents ? Very plausible
2 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 3 at 5:50 PM
$CVAC Really good write-up that perfectly summarizes CVAC's present situation. So if you want to bring your CVAC knowledge up to date or just discover CVAC, this is required reading. https://beyondspx.com/quote/CVAC/analysis/curevac-s-mrna-evolution-from-pioneer-to-integrated-powerhouse-nasdaq-cvac
0 · Reply
DocPharm
DocPharm Aug. 18 at 7:29 PM
$CVAC still have a few thousand left - when is the conversion? And how many for how many TYIA
0 · Reply
DaxCo
DaxCo Aug. 8 at 6:39 AM
1 · Reply
taxplanr
taxplanr Aug. 6 at 2:25 AM
HHS Sec Kennedy BARDA canceling 22 malignantRNA programs $BNTX $MRNA $PFE $CVAC https://truthsocial.com/@seckennedy/114978386245597771
0 · Reply
Jbjb90
Jbjb90 Jul. 24 at 2:12 PM
$SANA $PBM $LXRX added to all three today, sold out of $CVAC
0 · Reply
Jbjb90
Jbjb90 Jul. 20 at 2:31 AM
$CVAC Is this buyout a done deal or is there any chance someone comes in and makes a better offer? I made the mistake of selling my H E Equipment shares when united rental bought them out and then Herc swooped in at the last minute and made a better offer so i missed out on some profits.
1 · Reply
Jordand91
Jordand91 Jul. 11 at 6:55 PM
$NVAX go and check out $CVAC has a lot more promise than nova. Actually everything at this point has more promise than nova
3 · Reply
taxplanr
taxplanr Jul. 11 at 1:10 PM
$BNTX $MRNA $CVAC $BMY there is no future for malignantRNA in medicine
1 · Reply
taxplanr
taxplanr Jul. 9 at 2:20 PM
$BNTX $MRNA $CVAC $NVAX only sales plan https://jonfleetwood.substack.com/p/pegasus-uk-to-run-largest-ever-national
0 · Reply
StocktwitsNews
StocktwitsNews Jul. 8 at 5:05 AM
Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma $MRNA $NVAX $CVAC $GSK $TRAW https://stocktwits.com/news/equity/markets/cooling-us-bird-flu-wave-removes-tailwind-for-moderna-novavax-cure-vac-traws-pharma/chFvLokR5Qy
1 · Reply
justiceforb_85
justiceforb_85 Jul. 3 at 8:05 PM
$CVAC when does the deal close?
0 · Reply
taxplanr
taxplanr Jun. 30 at 2:31 PM
$MRNA $BNTX $CVAC $BMY please let everyone know about the Ivermectin Menbendazole Breast cancer treatment break throughs https://www.onedaymd.com/2024/08/ivermectin-in-stage-4-cancers-2024.html
0 · Reply
taxplanr
taxplanr Jun. 26 at 7:14 PM
Ivermectin and Menbendazole Glioblastoma testimonial after 5 months $BNTX $CVAC $MRNA $BMY https://makismd.substack.com/p/ivermectin-and-mebendazole-testimonial-52f?utm_source=post-email-title&publication_id=1385328&post_id=166913331&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
2 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 26 at 3:32 PM
$CVAC UBS Downgrades CureVac to Neutral, Lowers Price Target to $5.5
0 · Reply
taxplanr
taxplanr Jun. 26 at 1:47 PM
$BNTX $MRNA $PFE $CVAC American Academy of Pediatrics throws the CDC vaccine guidelines under the bus Who will people listen to? https://karenkingston.substack.com/p/american-academy-of-pediatrics-discredits?utm_source=post-email-title&publication_id=1103773&post_id=166846433&utm_campaign=email-post-title&isFreemail=false&r=18m8lm&triedRedirect=true&utm_medium=email
1 · Reply
taxplanr
taxplanr Jun. 26 at 1:43 PM
CDC picked apart and exposed at first ACIP meeting with new members $BNTX $MRNA $PFE $CVAC https://childrenshealthdefense.org/defender/acip-advisers-cdc-covid-vaccine-safety-claims/?utm_source=luminate&utm_medium=email&utm_campaign=defender&utm_id=20250625
0 · Reply
taxplanr
taxplanr Jun. 25 at 6:22 PM
$BNTX $MRNA $PFE $CVAC “Our findings suggest possible indirect transmission of ingredients or products of the COVID-19 vaccines, presumably through shedding, from people who received one or more of the COVID-19 injections." It just sounds like a bioweapon https://ijvtpr.com/index.php/IJVTPR/article/view/113
0 · Reply